ESC Premium Access

ASCEND - A randomized trial of aspirin versus placebo for primary cardiovascular prevention in 15,480 people with diabetes

Topic: Diabetes and the Heart

Congress Session

About the speaker

Professor Jane Armitage

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
10 presentations
2 followers

12 more presentations in this session

Opening question - ASCEND.

Thumbnail

Discussant review - The effect of randomization to aspirin in ASCEND.

Speaker: Professor S. Halvorsen (Oslo, NO)

Thumbnail

Questions from the audience and discussion.

Thumbnail

Concluding question - ASCEND.

Thumbnail

ASCEND - A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary cardiovascular prevention in 15,480 people with diabetes

Speaker: Professor L. Bowman (Oxford, GB)

Thumbnail

Access the full session

Hot Line Session 2

Speakers: Professor J. Armitage, Professor S. Halvorsen, Professor L. Bowman
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Related content

Open Access

LDL-c in the management of high CV risk: Changing the paradigm for prevention.

27 August 2021

ESC Premium Access

Will coronary atherosclerosis be eliminated?

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

This platform is supported by

logo Novo Nordisk